H1N1 (SWINE FLU) UPDATE FOR VESSELS

 

July 2009 - Since the first reported cases of a novel flu virus (H1N1) emerged in Mexico and the United States in April 2009, the disease has spread globally.  On June 11, 2009, the World Health Organization (WHO) declared the first pandemic in 41 years.  Most cases are mild and require no treatment, but novel H1N1 influenza virus still has the potential to reappear, possibly with increased severity, after several months time (multiple ‘waves’ are common with pandemics).

 

Symptoms of novel H1N1 (swine) flu in people are similar to the symptoms of regular human seasonal flu and include fever, cough, sore throat, body aches, headache, chills and fatigue.  Some people have reported diarrhea and vomiting associated with novel H1N1 flu.  Currently, people are who pregnant or have underlying health conditions appear to be at greater risk for developing a severe illness. 

 

Also similar to human seasonal flu, the novel H1N1 virus spreads person-to-person via respiratory droplets.  That means when someone sneezes or coughs they release the virus into the environment—potentially contaminating other people and surfaces.  If a contaminated finger or surface then comes into contact with a person’s mucous membranes (e.g. eyes, nose, and mouth), the person can become infected.  Infected people generally can be contagious up to 24 hours prior to developing symptoms and up to a week after symptom onset (though this period can be longer for kids).  Also, flu virus on surfaces usually remains viable for several hours.

 

What should vessels do moving forward?

 

Prevention and preparedness—with a focus on good hygiene and robust planning—are two areas to emphasize that can help mitigate the impact of any outbreak.  In particular, creating an atmosphere that encourages sound health and hygiene is the foundation of a basic flu prevention strategy. 

 

For instance, general guidance for vessels, given an increased risk of contracting influenza, is as follows…

  1. Avoid crowded places in locations with community transmission of flu.  The extent of avoidance should be in relation to the prevalence and perceived danger of the given flu strain.  For example, hypothetically speaking, in a location suffering from a deadly and rapidly spreading new form of influenza, shore movement at ports of call should be limited to essential activities only. 
  2. Cover your cough with tissues or your sleeve (not your hand).  Make sure tissues are readily available aboard ship.
  3. Promote regular hand-washing and provide alcohol-based hand sanitizer in common areas.
  4. In general, promote good hygiene and healthy habits.
  5. If concerned about possible contamination of surfaces with respiratory droplets from a potentially sick individual, wipe surfaces with an EPA-approved disinfectant that’s effective against viruses (http://www.epa.gov/oppad001/chemregindex.htm).  Fumigation is not needed.  Regardless, outside of the host, the flu virus usually “dies” within 24 hrs.
  6. Monitor employee health and isolate sick crew members.  Also, monitor the health of visitors coming aboard ship.  When isolating someone, consider both barrier protection and distance (at least 6 feet).  The goal is to prevent respiratory droplets from coughs and sneezes from coming into contact with other crew members or common surfaces. 
  7. Surgical masks are recommended for persons with symptoms of influenza and disposable N-95 respirators for those caring for sick crew members. 
  8. When flu vaccines become available, get them.
  9. Oseltamivir or zanamivir are the antiviral medications of choice for influenza.  Guidance for their use is available from the CDC (Interim Guidance on Antiviral Recommendations for Patients with Novel Influenza A (H1N1) Virus Infection and Their Close Contacts).  In general, antiviral medications will reduce the severity and duration of illness if given within 48 hours of developing symptoms.  They can also protect an individual from becoming ill if they’ve been exposed to the respiratory secretions of someone sick with the flu.  Depending on the perceived risk of vessel crew members contracting the flu, having a stockpile of antiviral medications aboard ship for treatment and disease control is a reasonable mitigation strategy.  
  10. If a suspect H1N1 influenza case is identified aboard a ship (see Interim Guidance on Case Definitions to be Used For Investigations of Swine-Origin Influenza A (H1N1) Cases) the captain is required by law to report the illness to the CDC Quarantine Station in the jurisdiction of the U.S. port where the ship is expected to arrive (see Quarantine Stations).  If the ship will not be arriving imminently at a U.S. port, Quarantine health authorities will assist ship officials with the management and isolation of the suspect case and the recommendations for other passengers and crew members.

 

Additionally, preparedness efforts should focus on plans and policies related to business continuity in the event of a major outbreak.  Are there plans in place that address staffing shortages?  What about supply or service interruptions?  Are improvements needed?  Have you taken into consideration the impact of potential disease control measures in ports of call? 

 

For more information on influenza preparedness and the current novel Influenza A H1N1 outbreak:

 

w  United States Flu information and updates: www.flu.gov

w  Federal guidance for cruise and cargo ships:

o   http://www.pandemicflu.gov/travel/cleaning_vessels.html

o   http://www.cdc.gov/h1n1flu/guidance/cruiseships.htm

w  World Health Organization: www.who.int/en/

w  United States Department of Labor Occupational Safety and Health: www.osha.gov/Publications/influenza_pandemic.html

 

For help preparing for a flu pandemic, please contact O’Brien’s Response Management Inc.  We have full-time staff members with advanced degrees in epidemiology and ample experience developing pandemic influenza plans, trainings, and exercises for clients—including multiple cities, counties, states, and corporations.  If interested, you can contact us by calling +1 (281) 320-9796 or by emailing Clint Ladd (clinton.ladd@obriensrm.com) for more information.